ASC30 subcutaneous (SQ) depot formulation achieved statistically significant and clinically meaningful placebo-adjusted mean weight loss of 7.5% at week 16 after ...

BACKGROUND: Peripheral artery disease (PAD) and its severe form, chronic limb-threatening ischemia (CLTI), significantly impair blood flow to the lower extremities, affecting millions of adults ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...

In a study published in Science, researchers reported that a single intramuscular injection helped mice and pigs recover ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

When we think about body fat, most of us focus on what we see in the mirror, the soft tissue we can pinch on our arms or waist. However, not all fat is created equal. Your body stores fat in two very ...

“The approval of additional subcutaneous dosing options represents a step forward in how we can deliver amivantamab in clinical practice for EGFR-mutated non-small cell lung cancer,” said Silvia ...

If approved, a subcutaneous formulation of anifrolumab would allow patients the ability to self-administer the medication outside of a hospital or clinic setting. The Food and Drug Administration (FDA ...

Please provide your email address to receive an email when new articles are posted on . Incorrect injection of an influenza vaccine can cause nodule formation or lipomas. Risk was lower when ...

VANCOUVER, BC, Dec. 16, 2025 /CNW/ -- Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes and Closed System Transfer Devices (CSTDs), ...

Daratumumab and hyaluronidase-fihj received FDA approval for high-risk smoldering multiple myeloma (SMM), showing significant PFS improvement in the AQUILA study. The AQUILA study reported a 51% ...